Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Detection Of Preclinical Cancer; Imagine What Kevetrin Will Do?

|Includes: Innovation Pharmaceuticals Inc. (IPIX)

Quote From Cited Source Below:

Scientists at Northwestern and Harvard universities say they've made a discovery that could lead to a blood test to predict cancer years before it's diagnosed.

They linked changes in blood cell telomeres - protective caps on DNA strands that are a biological marker of aging - to later development of cancer.

Telomeres shrink with age. In people who later were diagnosed with cancer, they initially shrank much faster - appearing to be 15 years older than those in people who didn't develop cancer. Then, three or four years before cancer was found in these people, the shrinking, or aging, of the telomeres stopped.

http://chicago.suntimes.com/health-care-news/7/71/562665/health-news-predicting-cancer-years-ahead-blood-test

Ella Ruth: Imagine high dose Kevetrin, with early stage cancer patients. DOES KEVETRIN VIA THE ACTIVATION OF THE P53, P21 OR MDM2, CAUSE OR PROMOTE HEALING AND THE PROPER FUNCTION OF THE BLOOD CELL TELOMERES? REMEMBER THERE ARE SCIENTISTS AT HARVARD, THAT REALLY CARE ABOUT THIS QUESTION!

Disclosure: The author is long 10,000 SHARES OF CTIX.

Additional disclosure: The scientific question raised due to this article might connect Kevetrin with anti-aging and prophylactic therapy against Kevetrin.